HomeOpen Access NewsPharmaceutical Industry

Pharmaceutical Industry

Psilocybin and IBS treatment: First psychedelic study in gastroenterology

In a groundbreaking first, psilocybin is entering gastroenterology. Dr. Erin Mauney leads a pioneering study exploring how psychedelic therapy could transform treatment for millions suffering from treatment-resistant Irritable Bowel Syndrome, offering new hope for gut-brain disorders.

What are the mental and physical health benefits of essential oils?

Essential oils have been used for centuries for their medicinal properties. However, scientists have only now started studying and exploring the potential benefits of essential oils.

Depression is not caused by low serotonin levels

Chemical imbalance theory debunked as there is "no convincing evidence" that depression is caused by low serotonin levels.

Vitamin B6 supplements help reduce anxiety and depression

Taking high-dose vitamin B6 tablets can reduce feelings of anxiety and depression, new research reveals.

The Decision-Making Guide to taking HRT

In this exclusive guide to HRT, menopause specialist Dr Deborah Lee, Dr Fox Online Pharmacy, explores the ups and downs involved in the decision to start taking HRT

Migraine drug can boost weight loss by suppressing appetite

Triptans, a commonly prescribed class of migraine drugs, can help with weight loss and treating obesity by suppressing appetite.

Cannabinoids as an alternative to opioids for chronic pain

Cannabinoids with high THC-to-CBD ratios can help to improve moderate, short-term chronic pain band may be an alternative to opioids.

Universal flu vaccine trial opens at NIH Clinical Center

A Phase 1 clinical trial of a universal flu vaccine has started inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Maryland.

Acoustic Cluster Therapy – A novel ultrasound-mediated drug delivery platform for therapeutic enhancement across multiple diseases

Optimising a drug’s ability to reach diseased body parts in adequate levels while avoiding healthy body parts – its tissue exposure and selectivity – is critical to therapeutic optimisation.

The importance of personalised medicine & technology in the future of medical cannabis

Dr Stephen Barnhill M.D from Apollon Formularies Plc discusses the potential for technology to upgrade personalised medicine for cannabis treatments.

UK Cannabis Industry – the next Scottish Whisky

Nick Morland, Tenacious Labs CEO, All-Party Parliamentary Group for CBD Products Secretariat, Jersey Cannabis Services Advisory Board Chair, writes about the UK Cannabis Industry – could this be the next Scottish Whisky?

Do labels efficiently tell you what’s in your weed strain?

Research finds that labels on weed often fail to adequately reflect products' chemical make-up and components of the weed strain.

Study explores cheaper way to produce compounds for pharmaceuticals

Researchers have developed a new tool that can make it easier and cheaper to fabricate the compounds needed for pharmaceuticals.

Ukrainian patients lose access to multiple sclerosis drug trial

Biotechnology giant Roche warns that multiple sclerosis (MS) drug trials are compromised in Ukraine - with patients losing access to crucial treatment.

Are animal CBD products safe?

Suzette Smiley-Jewell, PhD & Pamela J. Lein, PhD from the University of California, Davis, explore the extent to which animal CBD products are safe

Combining AI tech with drug development efforts

Can Artificial Intelligence (AI) change the process of drug development for the pharmaceutical industry?

Medical cannabis-based treatments: Research, production & distribution

Prof Trevor M Jones charts the priorities for research and development, production and distribution of medical cannabis-based treatments

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders